Evaluation of the Benefits for Overall Health Following Cochlear Implant Treatment in the Elderly Population

NCT ID: NCT03072862

Last Updated: 2024-01-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-11-06

Study Completion Date

2022-03-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to show that cochlear implant treatment improves the overall health related quality of life and general well-being in elderly individuals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is designed as an observational prospective repeated measures study with each subject acting as his/her own control. Subjects are evaluated subjectively at pre- and post-operative intervals that coincide with their routine visits to the clinic. Outcomes from routine practice and application of cochlear implant intervention are recorded through observational measures using clinical standards scales used widely in geriatrics and audiology. The study is aimed at collection of data for patients who have already made the decision together with their implant centre clinician for an implant device from the company Cochlear. Patients are approached for study participation prior to surgery by the caring clinician on a consecutive and voluntary basis and on condition of signing the patient informed consent.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Commercial Nucleus Cochlear Implant Systems

Commercial Nucleus Cochlear Implant Systems

Intervention Type DEVICE

Commercially available Nucleus Cochlear Implant Systems, including Data Logging functionality

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Commercial Nucleus Cochlear Implant Systems

Commercially available Nucleus Cochlear Implant Systems, including Data Logging functionality

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Unilateral CI candidates with bilateral post-lingual deafness with intention to treat
* ≥ 60 years at first unilateral cochlear implant
* Implant ear: meets all local criteria for cochlear implant treatment
* Contralateral ear: average pure tone thresholds indicate a moderately-severe to profound hearing loss (4 freq. average: 0.5, 1, 2 and 3 or 4 kHz \> 56 dBHL).
* Willingness to participate in and to comply with all study procedures
* Fluency in languages used to assess clinical performance
* Appropriate expectations from routine cochlear implant treatment
* Able to decide on study participation personally and independently sign their consent

Exclusion Criteria

* Significantly/severely dependent or fragile
* Unable to provide consent personally
* Unable to complete questionnaires for self-assessment independently
* Unilateral hearing loss
* Sequential and simultaneous bilateral cochlear implant recipients
* Ossification or other cochlear anomalies preventing full electrode insertion
* Retro cochlear or central origins of hearing impairment.
* Significant comorbidities preventing study participation (e.g. blindness, immobility or in a wheel chair, severe aphasia)
* Medical contraindications to surgery
* Clinic Standard fail criteria for cochlear implant candidacy in regards to chronic depression, dementia, and cognitive disorders.
* Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure and prosthetic device.
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cochlear

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bart Volckaerts, PhD

Role: STUDY_DIRECTOR

Cochlear

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Groupe Hospitalier de La Pitié Salpétrière

Paris, , France

Site Status

ENT Department-Hôpital Purpan

Toulouse, , France

Site Status

Bnai Zion Medical Center

Haifa, , Israel

Site Status

Rabin Medical Center (Beilinson)

Petah Tikva, , Israel

Site Status

ENT Otosurgery Department-Azienda Ospedaliera di Padova

Padua, , Italy

Site Status

ENT Department Ospedale Guglielmo da Saliceto

Piacenza, , Italy

Site Status

Complejo Hospitalario Universitario Insular Materno Infantil

Las Palmas de Gran Canaria, , Spain

Site Status

Clinica Universitaria de Navarra

Pamplona, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France Israel Italy Spain

References

Explore related publications, articles, or registry entries linked to this study.

Cuda D, Manrique M, Ramos A, Marx M, Bovo R, Khnifes R, Hilly O, Belmin J, Stripeikyte G, Graham PL, James CJ, Greenham PV, Mosnier I. Improving quality of life in the elderly: hearing loss treatment with cochlear implants. BMC Geriatr. 2024 Jan 4;24(1):16. doi: 10.1186/s12877-023-04642-2.

Reference Type DERIVED
PMID: 38178036 (View on PubMed)

Marx M, Mosnier I, Belmin J, Wyss J, Coudert-Koall C, Ramos A, Manrique Huarte R, Khnifes R, Hilly O, Martini A, Cuda D. Healthy aging in elderly cochlear implant recipients: a multinational observational study. BMC Geriatr. 2020 Jul 23;20(1):252. doi: 10.1186/s12877-020-01628-2.

Reference Type DERIVED
PMID: 32703167 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEL5671

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tinnitus and Cochlear Implants
NCT06085885 ENROLLING_BY_INVITATION